Veterinary Contract Manufacturing And Research Market: Market Size & Forecast 2026

The global veterinary contract manufacturing and research market spans a broad range of services, from early-stage formulation development and pre-clinical testing to clinical trial management and large-scale manufacturing of finished veterinary products. The market encompasses both contract research organizations (CROs) that provide scientific and regulatory support, and contract development and manufacturing organizations (CDMOs) that handle production and scale-up. Different research firms segment this market differently, with some focusing specifically on CRO and CDMO services while others include broader contract manufacturing, leading to varying total addressable market estimates across industry reports.

• •Market valued at approximately $6.27 billion in 2025 with projected growth toward $11-16 billion range by 2030-2034 depending on scope
• •Encompasses both research services (CRO) and manufacturing services (CDMO) across companion animal and livestock sectors
• •Estimates vary by firm due to differing definitions of what constitutes the core market versus adjacent services

The primary engine of market growth is the rising global population of companion animals and intensifying livestock production to meet protein demand, both requiring expanded veterinary product pipelines. Increasing regulatory complexity and the shift toward more sophisticated biologic and vaccine formulations have made in-house development and manufacturing less feasible for many animal health companies. Additionally, the broader trend of pharmaceutical and biotech outsourcing that transformed human healthcare in prior decades is now extending into veterinary medicine as companies seek cost efficiencies and specialized capabilities.

• •Growing pet humanization driving demand for advanced companion animal therapeutics and diagnostics
• •Intensifying livestock production and food safety requirements increasing need for veterinary vaccines and pharmaceuticals
• •Rising R&D costs and regulatory hurdles pushing animal health companies toward outsourced expertise and capacity

The market is broadly divided between companion animal and livestock segments, with contract research and manufacturing services tailored to each species-specific requirement. Service types range from formulation development, analytical testing, and stability studies through to clinical trial management, regulatory affairs support, and commercial-scale manufacturing. Geographically, North America and Europe currently represent the largest regional markets due to established animal health industries and stringent regulatory environments requiring specialized services, while Asia-Pacific is emerging as the fastest-growing region driven by expanding livestock sectors and increasing pet ownership in countries like China and India.

• •Companion animal segment growing rapidly alongside rising pet humanization trends in developed markets
• •Asia-Pacific region showing strongest growth momentum from expanding livestock operations and rising pet populations
• •Services span the full product lifecycle from early development through commercial manufacturing and post-market support

What are the recent trends and outlook?

Several significant trends are shaping the market's trajectory, including increased investment in veterinary biologics and monoclonal antibody therapies, which require more sophisticated manufacturing capabilities than traditional small-molecule drugs. The rise of precision medicine approaches for companion animals and growing emphasis on antimicrobial alternatives are creating new service demands for contract research and manufacturing partners. Over the forecast period through 2030-2033, the market is expected to maintain robust growth as the animal health industry continues its structural shift toward outsourced innovation and production, though exact growth rates vary by research firm and market definition.

• •Growing focus on veterinary biologics, monoclonal antibodies, and advanced vaccine platforms driving demand for specialized manufacturing expertise
• •Expansion into emerging markets creating opportunities for contract service providers to support localized production
• •Technological advances in continuous manufacturing and process intensification expected to reshape service offerings and capacity requirements